Baxter Pharmaceuticals India Private Limited - Company Profile

It is a pharma private limited company based in Vasana Chacharwadi, Gujarat, India, established in 2005.

2005 Vasana Chacharwadi, Gujarat, India Active

Last Updated: January 01, 2026

About Baxter Pharmaceuticals India Private Limited

Baxter Pharmaceuticals India Private Limited, a active private limited company, was established on 08 June 2005 in Vasana Chacharwadi, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230GJ2005PTC046211. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹2,000.00 Cr and a paid-up capital of ₹0.57 M.

Formerly known as Claris Injectables Limited, Claris Lifesciences International Limited. It upholds a compliant status. Employing 1,179 professional, Its leadership includes Sanju Dhawan (Director), Anuranjan Naresh (Additional Director), Tripti Sapra (Additional Director). Past directors included Rishikesh Satish Jaiwant, Chandrasingh Shivrambhai Purohit, Arjun Sushilkumar Handa. It holds ₹5.00 Cr open charges and ₹1,130.21 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Village : Vasana-Chacharwadi Tal : Sanand, Vasana Chacharwadi, Gujarat, 382213.

Company Details

CIN/LLPIN
U24230GJ2005PTC046211
Registration Number
046211
Incorporation Date
08 June 2005
Authorized Capital
₹2,000.00 Cr
Paid-Up Capital
₹0.57 M
ROC Code
Roc Ahmedabad
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 2,000.00 Cr as on 01-01-2026
Paid Up Capital ₹ 0.57 M as on 01-01-2026
Company Age 20 Year, 8 Months
Last Filing with ROC 31 Mar 2025
Open Charges ₹ 5.00 Cr as on 01-01-2026
Satisfied Charges ₹ 1,130.21 Cr as on 01-01-2026
Revenue Growth **** -11.17% (FY 2024)
Profit Growth **** 56.37% (FY 2024)
Ebitda **** 190.40% (FY 2024)
Net Worth -12.53% (FY 2024)
Total Assets -10.99% (FY 2024)

Comprehensive Company Insights

Explore comprehensive insights into Baxter Pharmaceuticals India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Baxter Pharmaceuticals India Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Sanju Dhawan	Director	09 Jul 2021	Current
Anuranjan Naresh	Additional Director	01 Oct 2024	Current
Tripti Sapra	Additional Director	01 Oct 2024	Current
Ashwin Prakash Upasane	Additional Director	18 Jun 2025	Current
Anurag Bharatkumar Pachchigar	Additional Director	01 Oct 2024	Current
Gurjeet Singh Bedi	Additional Director	23 Dec 2024	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Additional Director	30 Sep 2019	Past
Pramod Abcsdd	Director	27 Jul 2017	Past
Pramod Abcsdd	Director	27 Jul 2017	Past
Pramod Abcsdd	Director	01 Aug 2014	Past
Pramod Abcsdd	Additional Director	31 Jul 2017	Past
Pramod Abcsdd	Director	10 Jan 2019	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Baxter Pharmaceuticals India.

Baxter Pharmaceuticals India Private Limited, for the financial year ended 2024, experienced significant reduction in revenue, with a 11.17% decrease. The company also saw a substantial improvement in profitability, with a 56.37% increase in profit. The company's net worth observed a substantial decline by a decrease of 12.53%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

-11.17%

*******

Revenue from Operations

*******

-7.44%

*******

Total Assets

*******

-10.99%

*******

Profit or Loss

*******

56.37%

*******

Net Worth

*******

-12.53%

*******

EBITDA

*******

190.40%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Baxter Pharmaceuticals India?

In 2024, Baxter Pharmaceuticals India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹50,000,000.00

Satisfied Charges

₹11,302,077,000.00

Charges Breakdown by Lending Institutions

Uco Bank : 5.00 Cr

Latest Charge Details

Date	Lender	Amount	Status
16 Jul 2019	Uco Bank	₹5.00 Cr	Open
29 Mar 2016	Others	₹1.18 M	Satisfied
19 Sep 2015	Others	₹0.70 M	Satisfied
18 Sep 2015	Others	₹1.00 M	Satisfied
31 Oct 2014	Canara Bank	₹564.96 Cr	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Baxter Pharmaceuticals India?

Baxter Pharmaceuticals India has a workforce of 1179 employees as of Oct 31, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Baxter Pharmaceuticals India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Baxter Pharmaceuticals India's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Baxter Pharmaceuticals India

Recent Activity within the Organization

Annual General Meeting

Progress on Baxter Pharmaceuticals India Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
30 Sep 2025
Director Appointment

Ashwin Prakash Upasane was appointed as a Additional Director was appointed as a Additional Director on 18 Jun 2025 & has been associated with this company since 8 months . was recorded as a recent event.
18 Jun 2025
Balance Sheet

Baxter Pharmaceuticals India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was recorded as a recent event.
31 Mar 2025
Director Appointment

Progress on Gurjeet Singh Bedi was appointed as a Additional Director was appointed as a Additional Director on 23 Dec 2024 & has been associated with this company since 1 year 1 month . was documented.
23 Dec 2024
Director Appointment

Progress on Anuranjan Naresh was appointed as a Additional Director was appointed as a Additional Director on 01 Oct 2024 & has been associated with this company since 1 year 4 months . was documented.
01 Oct 2024
Director Appointment

Tripti Sapra was appointed as a Additional Director was appointed as a Additional Director on 01 Oct 2024 & has been associated with this company since 1 year 4 months . was recorded as a recent event.
01 Oct 2024

Explore recent activity and updates - View Recent Activity